Brugada J, Brugada R, Brugada P
Determinants of sudden cardiac death in individuals with the electrocardiographic pattern of Brugada syndrome and no previous cardiac arrest.
Circulation, 2003, 108, 3092-3096
dx.doi.org/10.1161/01.CIR.0000104568.13957.4F
Lozano JM, Alba MP, Vanegas M, Silva Y, Torres-Castellanos JL, Patarroyo ME
MSP-1 malaria pseudopeptide analogs: biological and immunological significance and three-dimensional structure.
BIOLOGICAL CHEMISTRY, 2003, 384, 71-82
dx.doi.org/10.1515/BC.2003.008
Costa A, Fernández-Real JM, Vendrell J, Broch M, Casamitjana R, Ricart W, Conget I
Lower rate of tumor necrosis factor-alpha -863A allele and higher concentration of tumor necrosis factor-alpha receptor 2 in first-degree relatives of subjects with type 2 diabetes.
METABOLISM-CLINICAL AND EXPERIMENTAL, 2003, 52, 1068-1071
dx.doi.org/10.1016/S0026-0495(03)00108-2
Antzelevitch C, Brugada P, Brugada J, Brugada R, Towbin JA, Nademanee K
Brugada syndrome: 1992-2002: a historical perspective.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41, 1665-1671
dx.doi.org/10.1016/S0735-1097(03)00310-3
Fernández-Real JM, Peñarroja G, Castro A, GarcÃa-Bragado F, Hernández-Aguado I, Ricart W
Blood letting in high-ferritin type 2 diabetes: effects on insulin sensitivity and beta-cell function.
Diabetes, 2002, 51, 1000-1004
dx.doi.org/10.2337/diabetes.51.4.1000
Shah G, Brugada R, Gonzalez O, Czernuszewicz G, Gibbs RA, Bachinski L, Roberts R
The cloning, genomic organization and tissue expression profile of the human DLG5 gene.
Bmc Genomics, 2002, 3, 6-6
Fernández-Real JM, Broch M, Vendrell J, Ricart W
--to: T. Skoog et al. (2001) Tumour necrosis factor-alpha(TNF-alpha) polymorphisms -857C/A and -863C/A are associated with TNF-alpha secretion from human adipose tissue
Diabetologia, 2002, 45, 149-150
dx.doi.org/10.1007/s001250200024
Brugada J, Brugada R, Antzelevitch C, Towbin J, Nademanee K, Brugada P
Long-term follow-up of individuals with the electrocardiographic pattern of right bundle-branch block and ST-segment elevation in precordial leads V1 to V3.
Circulation, 2002, 105, 73-78
dx.doi.org/10.1161/hc0102.101354
Wilde AA, Antzelevitch C, Borggrefe M, Brugada J, Brugada R, Brugada P, Corrado D, Hauer RN, Kass RS, Nademanee K, Priori SG, Towbin JA
Proposed diagnostic criteria for the Brugada syndrome: consensus report.
Circulation, 2002, 106, 2514-2519
dx.doi.org/10.1161/01.CIR.0000034169.45752.4A
Fontova R, Gutiérrez C, Vendrell J, Broch M, Vendrell I, Simón I, Fernández-Real JM, Richart C
Bone mineral mass is associated with interleukin 1 receptor autoantigen and TNF-alpha gene polymorphisms in post-menopausal Mediterranean women.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2002, 25, 684-690
dx.doi.org/10.1007/BF03345101
Shah G, Brugada R, Gonzalez O, Czernuszewicz G, Gibbs RA, Bachinski L, Roberts R
The cloning, genomic organization and tissue expression profile of the human DLG5 gene: Correction.
Bmc Genomics, 2002, 3, 14-14
dx.doi.org/10.1186/1471-2164-3-14
Vatta M, Dumaine R, Antzelevitch C, Brugada R, Li H, Bowles NE, Nademanee K, Brugada J, Brugada P, Towbin JA
Novel mutations in domain I of SCN5A cause Brugada syndrome.
MOLECULAR GENETICS AND METABOLISM, 2002, 75, 317-324
dx.doi.org/10.1016/S1096-7192(02)00006-9
Brugada J, Brugada P, Brugada R
SÃndrome de bloqueo de rama derecha, elevación del segmento ST en las derivaciones V1 a V3 y muerte súbita.
MEDICINA CLINICA, 2002, 118, 150-156
dx.doi.org/10.1016/S0025-7753(02)72313-0
Castellanos M, Castillo J, GarcÃa MM, Leira R, Serena J, Chamorro A, Dávalos A
Inflammation-mediated damage in progressing lacunar infarctions: a potential therapeutic target.
Stroke, 2002, 33, 982-987
dx.doi.org/10.1161/hs0402.105339
Serrano Rios M, Ascaso Gimilio JF, Blázquez Fernández E, Cabezas Cerraro J, Carmena RodrÃguez R, Escobar Jiménez F, Fernández-Real JM, Gabriel Sánchez R, Gomis de Barberá R, Grande Aragón C, Herrera Pomba JL, Pallardo Sánchez LF, Potau Vilalta N, Ricart Engel W, Rovira Loscos A, Zorzano Olarte A
Resistencia a la insulina y su implicación en múltiples factores de riesgo asociados a diabetes tipo 2.
MEDICINA CLINICA, 2002, 119, 458-463
dx.doi.org/10.1016/S0025-7753(02)73455-6
Brugada P, Brugada J, Brugada R
The Brugada syndrome.
Cardiac Electrophysiology Review, 2002, 6, 45-48
Fernández-Real JM, Peñarroja G, Castro A, GarcÃa-Bragado F, López-Bermejo A, Ricart W
Blood letting in high-ferritin type 2 diabetes: effects on vascular reactivity.
Diabetes Care, 2002, 25, 2249-2255
dx.doi.org/10.2337/diacare.25.12.2249
close arrow-circle-o-down arrow-left bars linkedin angle-double-up youtube-play instagram